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NEUROIMMUNOENDOCRINE PATHOLOGY AND COGNITIVE FUNCTION
IN TYPE 2 DIABETES

by

KRISTA WILD, M.A.

Under the Direction of Marise B. Parent, Ph.D.

ABSTRACT

Cognitive impairment among older adults with type 2 diabetes may worsen health
outcomes via negative impact on compliance with medical self-care recommendations.
Results of several previous studies indicate that cognitive deficits are present in older
European American adults with type 2 diabetes under some conditions, particularly
related to glucose dysregulation (as evidenced by high glycated hemoglobin, i.e.,
HbA1c). Despite the fact African Americans are disproportionately affected by diabetes
and suffer significantly greater numbers of complications and more severe
complications relative to European Americans, no published studies have examined
cognitive functioning among older African American adults with type 2 diabetes.
Further, markers of systemic inflammation have been associated with cognitive
impairment in several conditions, but this relationship has not been examined in older
adults with type 2 diabetes. The purpose of the present study was to determine

whether: 1) cognitive deficits are present in older African American adults with type 2
diabetes, and whether the deficits are related to 2) glucose dysregulation and 3)
systemic inflammation.
Several cognitive domains, including verbal memory and executive functions,
were assessed in 71 African Americans with type 2 diabetes who ranged from 60 to 80
years of age. Exclusionary criteria included dementia, depression, neurological
disease, or brain injury. Also measured were HbA1c and two markers of systemic
inflammation: C-reactive protein (CRP) and interleukin-6 (IL-6). Results showed that
higher HbA1c was significantly associated with poorer performance on several
measures of executive function and verbal memory measures that tap executive
function. Higher IL-6 was significantly associated with slower motor function and higher
semantic fluency. Higher CRP was significantly associated with improved performance
on measures of phonemic fluency, psychomotor speed and mental flexibility/working
memory, and fine motor dexterity, but only for those with extremely high levels of CRP;
when those participants were removed from the analyses, CRP was inversely related to
cognitive performance.
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CHAPTER 1: INTRODUCTION
Memory impairment is the most common cognitive complaint among individuals
who present for neuropsychological evaluation (Butters, Soety, & Glisky, 1998). The
prospect of memory loss is cause for concern, given the potential for significant
negative impact on many aspects of daily functioning and reduced quality of life
(Perlmutter et al., 1987). One medical group that may be particularly impacted by
cognitive impairment is older adults with type 2 diabetes, because outcomes in diabetes
depend largely on the patient’s consistent self-management of the condition. Given the
potential for cognitive problems to interfere with attempts to self-manage medical
problems and follow a physician’s recommendations, cognitive deficits among older
adults with diabetes could lead to further declines in health (Sinclair, Girling, & Bayer,
2000). In one longitudinal study of older adults with diabetes, even performance in the
low average range on a cognitive screening measure was associated with a 20%
increased risk of death 2 years later (McGuire, Ford, & Ajani, 2006).
Diabetes is a disorder in which the body does not produce or does not properly
utilize insulin, which is a hormone used in the metabolism of sugars, starches, and other
foods. Absence or impairment of insulin functioning in the body results in high levels of
glucose in the blood and urine (hyperglycemia); these increases are paralleled by
increases in brain extracellular glucose levels (McNay, McCarty, & Gold, 2001).
Diabetes has more than one known etiology, the most common of which are referred to
as type 1 and type 2 diabetes. Type 1 diabetes is secondary to a failure of insulin
production, and is usually diagnosed prior to age 30. In contrast, type 2 diabetes results
from the development of resistance to insulin, and is typically acquired in middle age or

2
later. Type 2 diabetes is the most common form of the disorder, representing at least
90% of the diabetes diagnoses in the U.S. (Laakso, 2003). Having diabetes increases
the risk of many serious complications, including cardiovascular disease, retinopathy,
neuropathy, and nephropathy. Cognitive deficits are associated with both type 1 and
type 2 diabetes, although they are observed less consistently in type 1 than in type 2
diabetics (Ryan & Geckle, 2000b).
Literature Review
Predictors of Cognitive Decline. Cognitive deficits are more likely to be found
among older than younger individuals with type 2 diabetes (for reviews see: Awad,
Gagnon, & Messier, 2004; Ryan & Geckle, 2000b). Although cognitive deficits have
been found in some studies in which middle-aged and elderly type 2 diabetics were
combined into a single group (Elias, Elias, D'Agostino, Silbershatz, & Wolf, 1997;
Gradman, Laws, Thompson, & Reaven, 1993; Perlmuter et al., 1984; Reaven,
Thompson, Nahum, & Haskins, 1990; Vanhanen et al., 1997; Worrall, Moulton, &
Briffett, 1993), studies comparing cognitive functions in middle-aged individuals with
type 2 diabetes to those of age-matched controls yield no group differences (Mattlar,
Falck, Rèonnemaa, & Hyyppèa, 1985; Zaslavsky, Gross, Chaves, & Machado, 1995).
Such results suggest that combining older and middle-aged adults with type 2 diabetes
into a single group might reduce the ability to detect group differences in cognitive
performance relative to nondiabetic controls (Lowe, Tranel, Wallace, & Welty, 1994;
Scott, Kritz-Silverstein, Barrett-Connor, & Wiederholt, 1998). The evidence suggests
that restricting the age range of a sample to older adults will maximize chances of
detecting impaired cognitive functioning in adults with type 2 diabetes.
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Acute and chronic glucose levels appear to be critical determinants of cognitive
functioning among adults with type 2 diabetes. Experimental manipulation of acute
glycemic levels reveals a significant association with cognitive performance among both
middle aged and older type 2 diabetics. For instance, Greenwood, Kaplan,
Hebblethwaite, and Jenkins (2003) tested a small group of middle-aged and older type
2 diabetes patients with varying levels of blood glucose, allowing them to serve as their
own controls. Under hyperglycemic conditions only, a relative decline in delayed recall
performance was observed on both a modified serial list learning task and an auditoryverbal paragraph recall task. In addition, older prediabetic patients with higher plasma
glucose levels show changes in cognitive function similar to those seen in elderly type 2
diabetics (U'Ren, Riddle, Lezak, & Bennington-Davis, 1990; Vanhanen et al., 1997).
Furthermore, in some cases acute administration of glucose impairs memory in healthy
adults (Craft, Murphy, & Wemstrom, 1994).
Chronic glucose levels also appear to be associated with cognitive deficits in type
2 diabetes. Glycemic control is a medical term that refers to average blood glucose
levels over time in a person with diabetes. One measure of glycemic control is glycated
hemoglobin. Hemoglobin is the compound in red blood cells that transports oxygen,
and the most common form of hemoglobin is called hemoglobin A. Glucose binds to
hemoglobin A, forming glycated hemoglobin. Glycated hemoglobin is commonly
designated as HbA1c and is elevated when plasma glucose levels are high. The
decomposition of glycated hemoglobin is slow and the buildup of glycated hemoglobin
lasts between 1 and 4 months. HbA1c reflects mean glucose levels over the past 2
weeks to 3 months (American Diabetes Association, 2006; Garg, Sharp, & Stutts,
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2006). ADA guidelines indicate that normal HbA1c is less than 6.0% (~120 mg/dL),
while an HbA1c value greater than 7.0% (~150 mg/dL) represents poor glycemic control
(American Diabetes Association, 2006). Several studies have shown an inverse
relationship between HbA1c and verbal memory in older adults with type 2 diabetes
(Gradman et al., 1993; Jagusch, Cramon, Renner, & Hepp, 1992; Perlmuter et al.,
1984; Reaven et al., 1990), although a few have found no such relationship (Lowe et al.,
1994; Zaslavsky et al., 1995).
Longer duration of diabetes also predicts poorer cognitive performance in both
elderly and middle-aged adults with type 2 diabetes (Cosway, Strachan, Dougall, Frier,
& Deary, 2001; Dey, Misra, Desai, Mahapatra, & Padma, 1997; Elias et al., 1997; Gregg
et al., 2000; Grodstein, Chen, Wilson, & Manson, 2001). Longer duration of poor
glycemic control may result in irreversible cognitive deficits (Awad, Gagnon, & Messier,
2004). Such duration-related cognitive changes are hypothesized to be due to
prolonged hyperinsulinemia causing or contributing to the development of vascular
disease. Hypoglycemic medications appear to significantly ameliorate cognitive
performance regardless of the duration of diabetes (Grodstein, Chen, Wilson, &
Manson, 2001), however, which suggests that glucose levels may exert a more
powerful influence on cognitive functioning than the putative structural changes that
occur over a prolonged course of diabetes.
Depression may also contribute to cognitive deficits among older patients with
type 2 diabetes, because depression is independently associated with poorer cognitive
functioning (Lezak, 1995). Increased levels of depression often co-occur with significant
medical conditions (Wells, Golding, & Burnam, 1988). A recent meta-analysis
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concluded that the presence of diabetes more than doubles the odds of depression
(Anderson, Freedland, Clouse, & Lustman, 2001). In some studies, controlling for
depression attenuated the degree of verbal memory deficits observed in older adults
with type 2 diabetes (Lindeman et al., 2001; Scott et al., 1998; Tun, Perlmuter, Russo, &
Nathan, 1987). In contrast, in other studies cognitive differences remained after
controlling for depression (Gregg et al., 2000; Perlmuter et al., 1984; Vanhanen et al.,
1997). Although it remains unclear why depression is a significant predictor in some
studies and not others, it is obviously important to include this variable in any study of
diabetes and cognitive function.
Type 2 diabetes is associated with an increased risk of cardiovascular disease
and thus stroke and vascular dementias (Harati, 1996). The findings of one prospective
study indicate that diabetics are significantly more likely than nondiabetics to develop
dementia (Ott et al., 1999). In another study there were no group differences in verbal
memory after excluding individuals who had been diagnosed with dementia from their
study of elderly diabetic patients and matched controls (Vanhanen et al., 1999). A
recent review examined a number of studies of cognitive functioning in older adults with
type 2 diabetes, and concluded that a significant proportion of the variance in verbal
memory could be accounted for by comorbid dementing processes (Awad, et al., 2004).
Some studies have excluded older adult diabetics with dementia, however, and still
found cognitive deficits (Mooradian, Perryman, Fitten, Kavonian, & Morley, 1988;
Vanhanen et al., 1997). These latter findings suggest that dementia is not the sole
cause of cognitive deficits among older type 2 diabetics.
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Diabetes is a cardiovascular risk factor. Other cardiovascular risk factors that
have been associated with cognitive deficits include obesity (Gunstad, Paul, Cohen,
Tate, & Gordon, 2006; Kuo et al., 2005), hypercholesterolemia (Kivipelto et al., 2001),
cigarette smoking (Hill, Nilsson, Nyberg, & Backman, 2003; Kalmijn, van Boxtel,
Verschuren, Jolles, & Launer, 2002), and hypertension (Kuo et al., 2005; Vicario,
Martinez, Baretto, Diaz Casale, & Nicolosi, 2005; Waldstein, Brown, Maier, & Katzel,
2005). Although antihypertensive drugs appear to be protective against dementia
(Forette et al., 1998), they do not improve cognitive function in older, non-demented
adults with moderate hypertension (Prince, Bird, Blizard, & Mann, 1996). These latter
findings suggest that hypertension can negatively impact cognition through means other
than contributing to the development of vascular dementias.
Inflammation may also contribute to cognitive deficits associated with type 2
diabetes. Inflammation occurs as part of the body’s nonspecific immune response.
Nonspecific immunity is believed to be the body’s first line of defense against infection
or injury because it is faster than a specific immune response (Maier & Watkins, 1998).
A specific immune response involves the development of antibodies meant to fight
specific foreign substances that enter the body, and may take several hours or days to
develop. In contrast, a nonspecific immune response can be seen within as little as 1
hour after a foreign substance enters the body. The nonspecific immune response
includes activity by phagocytes (“eating cells”) that recognize and respond quickly to
foreign substances and injured tissue in the body. Responses include killing and
interfering with the growth of foreign cells, and releasing proinflammatory proteins called
cytokines. These cytokines initiate a local inflammatory response and attract other
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immune cells, which can help heal the injured area (Maier & Watkins, 1998). There are
also anti-inflammatory cytokines that act to dampen the immune response (O'Brien,
Scott, & Dinan, 2004). In addition to their local effects, proinflammatory cytokines also
produce a more global bodily response to the infection or injury called the acute-phase
response. This involves a number of physiological adjustments including fever, and
sickness behavior, a collection of behaviors, including reduced activity, hypersomnia or
hyposomnia, and anorexia (Maier & Watkins, 1998; Reichenberg et al., 2001). It is
believed that these responses to infection and injury have evolved as adaptive
strategies to help the body conserve resources in order to best combat infection and
heal. When the inflammatory response continues for an extended duration, however,
risk of other illnesses and problems may increase.
There is a link between inflammation and diabetes. For instance, hyperglycemic
crisis is associated with an increase in proinflammatory cytokines and other peripheral
markers of inflammation (Stentz, Umpierrez, Cuervo, & Kitabchi, 2004). Inflammation is
also associated with impaired glucose regulation (Barzilay et al., 2001; TemelkovaKurktschiev, Henkel, Koehler, Karrei, & Hanefeld, 2002) and appears to precede and
predict the development of diabetes (Barzilay et al., 2001; Duncan et al., 2003;
Pradhan, Manson, Rifai, Buring, & Ridker, 2001; Schmidt et al., 1999; Spranger et al.,
2003). For instance, high levels of the inflammatory markers c-reactive protein (CRP)
and interleukin-6 (IL-6) are associated with an increased risk of developing type 2
diabetes (Pradhan, Manson, Rifai, Buring, & Ridker, 2001). Importantly, increases in
peripheral levels of these markers can impair the functioning of the central nervous
system (Wilson, Finch, & Cohen, 2002).
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Inflammation can impair cognition. High levels of the inflammatory markers CRP
and IL-6 are associated with accelerated cognitive decline in healthy older adults
(Engelhart et al., 2004; Teunissen et al., 2003; Weaver et al., 2002; Yaffe et al., 2003)
and in older adults with metabolic syndrome (Yaffe et al., 2004). Metabolic syndrome is
a cluster of several commonly occurring disorders, including impaired glucose
regulation. Metabolic syndrome is diagnosed in the presence of three or more of the
following: elevated waist circumference (> 40” in men; > 35” in women), elevated serum
triglycerides (> 150 mg/dL), reduced HDL cholesterol (< 40 mg/dL in men; < 50 mg/dL in
women), hypertension (> 130/85 Hg), or elevated fasting glucose (> 100 mg/dL). Older
adults with metabolic syndrome and high inflammation are at increased risk for cognitive
decline, whereas those with metabolic syndrome and low inflammation are not (Yaffe et
al., 2004). These latter findings in particular suggest that inflammation impacts
cognition. This interpretation is supported by research in rodents showing that
increases in neural levels of proinflammatory cytokines, particularly in the hippocampus,
impair memory (Brennan, Beck, & Servatius, 2004; Gemma, Fister, Hudson, & Bickford,
2005; Maher, Nolan, & Lynch, 2005; Samuelsson, Jennische, Hansson, & Holmang,
2006). Moreover, decreasing brain levels of proinflammatory cytokines can reverse
memory deficits (Balschun et al., 2004; Gemma et al., 2005). To date there have been
no studies specifically examining the association between inflammation and cognition in
type 2 diabetes.
Diabetes and Cognition. Older adults with type 2 diabetes appear to have
impairments in verbal memory (Elias et al., 1997; Gradman et al., 1993; Greenwood et
al., 2003; Lucas et al., 2005; Mooradian et al., 1988; Perlmuter et al., 1984; Perlmuter,
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Tun, Sizer, McGlinchey, & Nathan, 1987; Reaven et al., 1990; Vanhanen et al., 1997).
In studies examining verbal memory abilities in this population, the measures employed
to assess verbal declarative memory typically consisted of standardized or experimental
versions of word list learning tasks or paragraph recall tests. Findings include: 1)
decrements in the number or percentage of list words recalled relative to age-matched
nondiabetic controls (Mooradian et al., 1988; Perlmuter et al., 1984; Perlmuter et al.,
1987; Reaven et al., 1990; Vanhanen et al., 1997), 2) increased risk of impaired
immediate and delayed memory on a paragraph recall task related to duration of
diagnosis (Elias, Elias, D'Agostino, Silbershatz, & Wolf, 1997), and 3) a relative decline
in delayed recall performance on both a serial list-learning task and an auditory-verbal
paragraph recall task under experimentally induced hyperglycemic conditions
(Greenwood et al., 2003). Among middle-aged and older non-diabetic individuals with
impaired glucose tolerance, there is a significant association between verbal memory
deficits on a paragraph recall task and hippocampal atrophy, independent of age and
score on a dementia screening measure (Convit, Wolf, Tarshish, & de Leon, 2003).
This suggests a strong positive relationship between hippocampal integrity and verbal
declarative memory performance in this population.
Although the primary cognitive deficit among older adults with type 2 diabetes is
typically purported to involve verbal declarative memory, there are compelling reasons
to suspect that deficits in executive functioning may play a more critical role. Executive
functions include the ability to think abstractly and to plan, initiate, sequence, monitor,
and inhibit complex, goal-directed behavior (DSM-IV; American Psychiatric Association,
1994). Relative to other cognitive abilities, executive functions appear to be
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disproportionately affected by cardiovascular risk factors and disease. Executive
dysfunction has been linked to hypertension in older adults (Vicario, Martinez, Baretto,
Diaz Casale, & Nicolosi, 2005), and is associated with acute elevations in blood
pressure in otherwise healthy older adults (Kuo et al., 2004). Furthermore, in a study of
older adult African Americans, a summary cardiovascular risk score was associated
with impairment in executive functions, but not in other cognitive skills, such as episodic
memory or visuospatial function (Pugh, Kiely, Milberg, & Lipsitz, 2003). Given that
diabetes is a cardiovascular risk factor, in the absence of any other information it would
be reasonable to hypothesize that the primary cognitive deficit associated with type 2
diabetes is executive.
It is possible that, in some instances, a result that is interpreted as showing a
verbal memory deficit actually reflects a problem with executive functions. The most
common ways to assess verbal learning and memory are paragraph recall tasks such
as the Logical Memory subtest from the Wechsler Memory Scale, and word list learning
tasks like the California Verbal Learning Test (CVLT). Initial correlational research
indicated that the two tests were highly related (Delis, Cullum, Butters, & Cairns, 1988),
and might be used interchangeably. Subsequent studies, however, have revealed
critical differences between the two tasks. For example, compared to healthy controls,
adults with executive dysfunction are impaired on CVLT-II but not on Logical Memory
(Brooks, Weaver, & Scialfa, 2006; Tremont, Halpert, Javorsky, & Stern, 2000). In fact,
the CVLT measures a combination of verbal learning and memory, conceptual ability,
and strategic organization (Lezak, 1995), and requires intact executive functions for
adequate performance. A recent review study (Awad et al., 2004) revealed that adults
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with type 2 diabetes are more commonly impaired on “noncontextual” word list learning
tasks, which require examinees to structure the information, than on paragraph
recall/contextual tasks, in which the information is provided to examinees in a structured
format. Thus, interpreting poor performance on the CVLT as being indicative of a verbal
memory deficit could be misleading.
The CVLT consists of a 16-item word list which is read aloud several times,
followed each time by a free recall trial and, after 20 minutes, a delayed free recall trial.
Each of the 16 words on the list belongs to one of four semantic categories (e.g., fruits,
herbs and spices, articles of clothing, and tools). The ability to detect and make use of
categories to facilitate performance is a common feature of tasks designed to measure
the integrity of executive functions. Optimal CVLT performance is obtained when the
semantic categories of the words are noticed and used spontaneously to organize list
words during encoding and to facilitate later recall (Alexander, Stuss, & Fansabedian,
2003; Gershberg & Shimamura, 1995). A failure of subjective organization as a
learning and recall strategy may result in significant reductions in the number or
percentage of list words freely recalled. Previous studies of older adults with type 2
diabetes using word list learning tasks typically reported only the total number or
percentage of words recalled across all learning trials (Perlmuter et al., 1987; Reaven et
al., 1990). When such data are presented in isolation, the source of the cognitive deficit
is ambiguous, and could reflect deficits other than verbal memory. Consequently, it is
impossible to determine whether an executive deficit contributed to a poor performance
on this measure without examining other CVLT performance indicators, such as
subjective strategy use. The semantic clustering score provides a measure of one
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particularly effective type of strategy an examinee could employ in order to facilitate the
encoding and subsequent retrieval of list words. The CVLT-II, a revised version of the
CVLT released in 2000, includes several changes, including a larger normative sample,
improved word lists, and revised scoring methods for the semantic clustering indices to
adjust for chance levels of semantic clustering during word recall.
The relationship between type 2 diabetes and executive functions is inconsistent.
Poor performance on measures of executive function has been found in some studies of
adults with type 2 diabetes (Elias et al., 1997; Gregg et al., 2000; Perlmuter et al., 1984;
Reaven, Thompson, Nahum, & Haskins, 1990; Vanhanen et al., 1999), but not in others
(Gradman et al., 1993; Greenwood et al., 2003; U'Ren et al., 1990). Group differences
between adults with type 2 diabetes and controls have been observed on several
different measures of executive function, including: Trail Making Test, part B (Gregg et
al., 2000; Reaven et al., 1990; Vanhanen et al., 1999), Stroop Interference (Ryan &
Geckle, 2000a), Phonemic Fluency (Hewer, Mussell, Rist, Kulzer, & Bergis, 2003; Lowe
et al., 1994), Semantic Fluency (Kanaya, Barrett-Connor, Gildengorin, & Yaffe, 2004),
and Wisconsin Card Sorting Test (WCST; Reaven, Thompson, Nahum, & Haskins,
1990). Symbol Digit Modalities Test (SDMT) is a measure of processing speed and
working memory. SDMT (written version) did not differentiate adults with and without
diabetes (U'Ren, Riddle, Lezak, & Bennington-Davis, 1990). Given that adults with type
2 diabetes purportedly have verbal memory deficits, any difficulties on SDMT may
become more apparent when the oral version is administered.
Using neuropsychological tests to isolate distinct executive deficits can be
difficult because all neuropsychological tests categorized as executive function
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measures require multiple executive functions (Daniels, Toth, & Jacoby, 2006). In
addition, the executive functions attributed to various measures vary across authors and
studies, and may change depending on the age groups and participant populations in a
given study. Thus, different outcomes on these tests do not clarify which executive
functions might be impaired by diabetes. Nonetheless, aside from WCST, a common
thread that may underlie the majority of executive tasks on which group differences
between adults with and without type 2 diabetes have been detected is working
memory. In fact, there is evidence linking CVLT performance and working memory. In
one study, two CVLT factors—general verbal learning and working memory—along with
Trails B and Digit Span were significantly correlated with a canonical variable that
accounted for 29% of the variance in the data (Vanderploeg, Schinka, & Retzlaff, 1994).
In PET studies of healthy participants engaged in encoding word lists with varying
demands for semantic organization, use of semantic organization strategies was
associated with increased regional cerebral blood flow (rCBF) in dorsolateral prefrontal
cortex (DLPFC; Fletcher, Shallice, & Dolan, 1998; Savage et al., 2001). Several
imaging studies indicate that DLPFC activation is associated with conditions that require
monitoring, manipulating and/or updating the contents of working memory (Blumenfeld
& Ranganath, 2006; Gerton et al., 2004; Staresina & Davachi, 2006; Volle et al., 2005).
Diabetes and African Americans. Surprisingly, there do not appear to be any
comprehensive studies of cognitive function in African-American elders with type 2
diabetes. Compared to Americans of European descent, African Americans are
disproportionately affected with type 2 diabetes (Brancati, Kao, Folsom, Watson, &
Szklo, 2000; Harris et al., 1998; Robbins, Vaccarino, Zhang, & Kasl, 2000). Failure to
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take medication because of forgetting to do so is a significant predictor of poor glycemic
control in African Americans (Hill-Briggs et al., 2005), indicating that cognitive deficits
may have a strong impact on health in this population. Importantly, the effects of type 2
diabetes on cognition may be moderated by ethnicity. For example, although cognitive
deficits are found in older adult European Americans with type 2 diabetes, none were
found in elderly Native Americans with type 2 diabetes once the effects of depression
were removed (Lowe, Tranel, Wallace, & Welty, 1994). Contrary to expectations based
on studies of older adult Caucasians, one study of 43 African American participants
aged 43-82 years (M = 59) showed that higher levels of HbA1c predicted improved
performance on a measure of attention, and was marginally associated with better
executive functions (Izquierdo-Porrera & Waldstein, 2002). The fact that middle aged
participants were included and that only 19% of the participants (N = 9) had selfreported diabetes diagnoses, however, make it difficult to draw any strong conclusions
from this study about the relationship between cognition and diabetes in African
Americans. A study employing a larger sample of older adult African Americans with
physician-confirmed diagnoses of type 2 diabetes and which excludes middle aged
participants would help to clarify the relationship between cognition and diabetes in this
population.
Present Study. The purpose of the present study was to determine whether: 1)
cognitive deficits are present in older African American adults with type 2 diabetes, and
whether they are related to 2) glucose dysregulation and 3) inflammation. An additional
aim of the present study was to obtain a more comprehensive analysis of executive
functions in older adults with Type 2 diabetes, and to determine whether CVLT-II
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subjective organization in the form of semantic clustering is impaired in this population.
To address these objectives, this study compared scores of older adults with type 2
diabetes with published normative data on measures of cognitive function that included
multiple measures of verbal declarative memory and of executive function.
Subsequently, participants’ cognitive test scores, HbA1c levels (an indicator of glucose
regulation), and levels of CRP and IL-6 (two markers of inflammation) were analyzed
statistically in order to identify any relationships between cognitive performance,
glucose regulation, and inflammation. CRP and IL-6 were selected as the two markers
of inflammation because of extensive evidence linking these markers with cognitive
deficits (Engelhart et al., 2004; Schmidt et al., 2002; Samuelsson et al., 2006;
Teunissen et al., 2003; Weaver et al., 2002; Yaffe et al., 2004; Yaffe et al., 2003).
Specifically, higher levels of IL-6 and CRP have been associated with increased rates of
cognitive decline (Yaffe et al., 2003) and dementia (Engelhart et al., 2004; Schmidt et
al., 2002) in healthy older adults, and in older adults with metabolic syndrome (Dik et al.,
2007; Yaffe et al., 2004). Higher baseline plasma IL-6 in a large sample of nondisabled
elderly people was associated with an increased risk of cognitive decline at a 7-year
follow-up (Weaver et al., 2002). In a sample of healthy elderly people, higher CRP
levels at baseline were associated with a decline in performance on a word list learning
task over a 6-year follow-up period (Teunissen et al., 2003).
Hypotheses and Predictions. The first hypothesis was that older AfricanAmerican adults with uncontrolled type 2 diabetes would have cognitive deficits,
particularly in verbal declarative memory and executive functions. It was predicted
that participants with type 2 diabetes would score significantly below the mean for
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healthy controls in published normative data on CVLT-II measures of immediate and
delayed recall and semantic clustering. In addition, it was expected that participants
with type 2 diabetes would perform significantly below average according to published
norms for healthy controls on measures of executive function tapping working memory,
including: Trail Making Test Part B, Stroop Color-Word, Phonemic and Semantic
Fluency, and Symbol Digit Modalities Test. It was also predicted that participants with
type 2 diabetes would perform in the normal range according to published normative
data for healthy control participants on measures of memory that are less dependent on
executive functions (i.e., paragraph recall), and on other cognitive measures (e.g.,
simple attention, visuospatial judgment, fine motor dexterity).
The second and third hypotheses were that cognitive deficits would be
significantly predicted by glucose dysregulation (high HbA1c) and inflammation
(elevated levels of the pro-inflammatory markers CRP and IL-6). It was predicted
that participants with 1) high HbA1c and/or 2) high CRP and IL-6 levels would score
significantly lower than participants with normal levels of HbA1c and/or normal CRP and
IL-6 levels on CVLT-II immediate and delayed recall and semantic clustering, and on
measures of executive function, including: Trail Making Test Part B, Stroop Color-Word,
Phonemic and Semantic Fluency, and Symbol Digit Modalities Test. It was also
predicted that HbA1c and the inflammation markers would not predict performance on
measures of memory that are less dependent on executive functions (i.e., paragraph
recall), or on other cognitive measures (e.g., simple attention, visuospatial judgment,
fine motor dexterity).
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CHAPTER 2: METHOD
Participants
Potential participants were identified via a database of patient records at the
Diabetes Clinic at Grady Memorial Hospital. Individuals with a diagnosis of type 2
diabetes who met other demographic criteria for the study were contacted by phone and
invited to participate in the study. Those individuals who expressed interest in the study
were asked a series of screening questions in order to verify their suitability for the
study. Exclusionary criteria included: 1) history of head injury or major neurological
disorder (including cerebral vascular accident and recent myocardial infarction), 2)
current clinically significant levels of depression or anxiety, or history of other major
psychiatric disorder, 3) significant and uncorrected sensory deficits (e.g., vision,
hearing), and 3) current or previous history of substance abuse, including alcohol.
Alcohol abuse was defined as two or more drinks per day in women, and three or more
drinks per day in men. In addition, given that estrogen replacement therapy in women
affects cognition in differing ways depending on factors such as timing of therapy
initiation (MacLennan et al., 2006) and comorbid medical conditions (Grady et al., 2002;
MacLennan et al., 2006), female participants recruited for the study were not on
estrogen replacement therapy. Individuals who met criteria and agreed to participate in
the study were instructed that on the day of their appointment for testing they were to
take their normally prescribed medications and to bring along their glasses and/or
hearing aids.
Of the 85 participants enrolled in the study, 14 participants were excluded from
or discontinued testing. Reasons for being excluded from testing included: Impaired

18
performance on measures screening for dementia (n = 3) or depression (n = 4),
reported history of excluded neurological conditions (n = 4), significant sensory
impairments (n = 3). In addition, one participant discontinued testing for undisclosed
reasons. Patients excluded from the study based on dementia and depression
screenings were referred for psychiatric or neurological examinations. The remaining
71 participants were African American adults (62 females and 9 males) who ranged in
age from 60 to 80 years (M = 67.01; SD = 5.0).
Measures
Medical variables that were measured included weight, blood pressure,
abdominal circumference, and serum levels of HbA1c, CRP, and IL-6. The
neuropsychological tests that were administered are commonly used, standardized
measures of intellectual and cognitive functioning. A listing and description of the
measures follows. Although several of the tests tap more than one cognitive domain, in
the following list each test was assigned to a single cognitive domain.
Mood Assessment. The Geriatric Depression Scale (GDS; Yesavage et al.,
1982) consists of 30 statements about the examinee’s current/recent feelings and
behaviors which are read aloud to the participant. The examinee responds with “yes” or
“no” to each statement.
Cognitive Screening. The Modified Mini-Mental State Examination (3MS; Teng &
Chui, 1987) is a screening test for memory problems and dementia. This measure
probes abilities across a number of areas, including orientation (e.g., to self, time, date,
place), memory, attention and calculation, spoken and written language, and the ability
to copy and remember named objects. Clock Drawing (Spreen & Strauss, 1998) is a
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screening test that assesses cognitive or visuospatial impairment. The examinee draws
a clock, including the numbers and the hands at a time designated by the examiner.
Estimated IQ. The North American Adult Reading Test (NAART; Blair & Spreen,
1989) is a reading test consisting of 61 irregularly spelled words that examinees read
aloud. Accuracy of pronunciation of list words is used to estimate verbal IQ. NAART
and years of education can be used in a formula to predict a WAIS-R Vocabulary score
(Uttl, 2002).
Attention. The Digit Span (DS) subtest from the Wechsler Memory Scale-Third
Edition (WMS-III; Wechsler, 1997) is a brief test of simple auditory attention and
auditory-verbal working memory. The examiner reads aloud increasingly long series of
digits, and the examinee attempts to repeat back the digit strings in the same order
(Digits Forward), or in reversed order (Digits Backward).
Memory. During the Logical Memory (LM) subtest of the WMS-III, the examiner
reads aloud two short stories. After each story, the examinee attempts to recall verbally
as much of the story as possible. Following a distraction-filled delay, the examinee
verbally recalls the stories again. The CVLT-II (Delis, Kramer, Kaplan, & Ober, 2000)
assesses several aspects of verbal learning, organization, and memory. Examinees are
read a list of words and asked to recall them in a series of trials, and then again
following a distraction-filled delay. Recognition is also probed.
Executive Functions. The Trail Making Test (TMT; Reitan & Wolfson, 1985) is a
timed measure of motor speed, visual attention, and working memory. The examinee
draws lines on a page connecting consecutive series of numbers (Trails A) or
alternating numbers and letters (Trails B). The Stroop Color and Word Test (SCWT;
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Golden, 1978) is a timed measure of attention, mental speed, and mental control. The
examinee names the colors of squares printed on a page, reads words printed on a
page (all are names of colors), and then names the color of the ink in which some words
(which name different colors) are printed. The Symbol Digit Modalities Test (SDMT;
Smith, 1982) is a measure of mental speed, motor speed, visual scanning, and mental
flexibility/working memory. The examinee pairs specific numbers with given geometric
figures under timed conditions. The Controlled Oral Word Association Test (COWAT;
Benton, Hamsher, & Sivan, 1994; Spreen & Strauss, 1998) is a set of tasks measuring
speed and fluency of verbal thought processes. Phonemic fluency tasks assess a
person’s ability to rapidly produce words beginning with a given letter. Semantic fluency
tasks measure a person’s ability to rapidly produce words fitting into a particular
semantic category (e.g., animals).
Language. The Boston Naming Test (BNT; Kaplan, Goodglass, & Weintraub,
2001) assesses object naming ability through spontaneous responses and the need for
various types of cueing. The examinee views a series of 60 drawings of objects, and
names each item aloud within a 20-second time frame.
Visuospatial Skill. Judgment of Line Orientation (JOLO; Benton, Sivan,
Hamsher, Varney, & Spreen, 1994) is a measure of visuospatial judgment. Initially the
examinee is presented with an array of numbered lines arranged at varying angles.
Subsequently the examinee must correctly identify by number the orientations of a
series of line pairs presented in isolation from the array.
Motor Skill. The Grooved Pegboard Test (GPT; Lafayette Instrument Company,
1997) is a timed measure of fine motor coordination consisting of a pegboard with 25
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randomly positioned slots. Pegs with a ridge along one side must be rotated to match
the hole before they can be inserted.
Procedure
Testing took place in the Outpatient Research Unit of Grady Diabetes Clinic at
Grady Memorial Hospital. After the study was fully described and consent was
obtained, participants were screened for depression and dementia. Participants who
passed the screenings underwent a battery of neuropsychological testing consisting of a
series of paper and pencil tests, which lasted approximately 2 hours. Following
neuropsychological testing, several medical variables were measured, including blood
pressure, abdominal circumference, and weight. Body Mass Index (BMI) was
calculated using the weight measurement obtained during the appointment and
participants’ self-reported height. Finally, a phlebotomist took a blood sample from the
participant’s arm in order to measure serum levels of CRP, IL-6, and HbA1c.
Participants were paid $30 for each complete session of neuropsychological testing.
During the informed consent process, participants were informed that they had a right to
discontinue participation in the study at any time. They were also informed that
participants who elected to stop participating in the study would receive a prorated
amount of compensation at the rate of $10 per hour of completed testing. Prior to the
initiation of the study, IRB approval was obtained from both Georgia State University
and Emory University.
Data Analyses
All data were entered into SPSS, checked for accuracy, and screened for outliers
and violations of the assumptions of relevant statistical tests. One variable (IL-6) was
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log transformed to reduce skewness. Descriptive statistics, including means and
standard deviations, were compiled for all demographic, biomedical, and
neuropsychological measures. As constraints on participant recruitment did not permit
the recruitment of a control group, scores from measures of cognitive functioning were
compared with demographically appropriate normative data for the general population, if
available, and converted into standard scores. Scores from several neuropsychological
measures were then categorized to indicate the percentages of participants falling into
specified z-score ranges.
Mayo’s Older African American Normative Studies (MOAANS; Lucas et al., 2005)
was the source of ethnically appropriate normative data grouped by age and education
level for the following measures: Stroop Test, Trail Making Test, Phonemic Fluency –
CFL, Semantic Fluency – Animal Naming, and Boston Naming Test. Normative data for
Grooved Pegboard and Phonemic Fluency – FAS was grouped by ethnicity, sex, age,
and education (Heaton, Miller, Taylor, & Grant, 2004). Normative data for the CVLT-II
was obtained via the CVLT-II scoring software, which controls for age and sex only;
normative sample cell sizes were too small to adequately stratify the sample across
education levels (Delis et al., 2000). Normative data for WAIS-III Digit Span and WMSIII Logical Memory were obtained from the WAIS-III/WMS-III/WIAT-III computer scoring
software program (The Psychological Corporation, 2001), which includes demographic
corrections for ethnicity, sex, age, and, education level. Normative data for SDMT were
obtained from the test manual (Smith, 1982), and corrects for age (to 78 years) and
education (12 years or less or 13 years or more). No normative data were available for
the following measures: Semantic Fluency – Boys Names, and a 15-item version of
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Judgment of Line Orientation in which the odd items from either form H or form V were
administered.
Predictions about the association between HbA1c, IL-6, and CRP and cognition
were tested using a series of hierarchical multiple regression analyses. Criterion
variables were select raw scores from the administered neuropsychological measures.
Due to their covariance with the criterion variables, age and reading level (NAART)
were controlled for in all analyses by regressing these variables on the criterion variable
at the first step. Age and education are two of the strongest predictors of performance
scores on measures of neuropsychological functioning. In the current study, reading
level was chosen as a proxy for education level in analyses because studies have
shown that: 1) among African American elders, reading level falls significantly below
that predicted by self-reported education level (O'Bryant et al., 2007), and 2) reading
level appears to be related to aspects of the educational experience that are important
for performance on cognitive tests across several domains (Manly, 2005). Predictor
variables were added to all regression equations in the following order: 1) age and
NAART score, 2) HbA1c, and 3) IL-6, and CRP. Given that glucose regulation is a
relatively robust predictor of cognitive performance across studies, HbA1c was entered
alone in the second block, and the more exploratory predictor variables measuring
inflammation (IL-6 and CRP) were entered together in the third step. Sets of hierarchical
multiple regression analyses will be presented grouping test scores from measures of 1)
executive function, and 2) verbal memory. A third set of hierarchical multiple regression
analyses consisted of scores from cognitive measures on which no significant effects of
the independent variables were predicted.
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CHAPTER 3: RESULTS
Descriptive Statistics
Table 1 shows frequencies, means, standard deviations, and variances for
demographic, biomedical, and psychological variables. Participants were predominantly
female (87.3%) and had 11.3 + 2.6 years of education (5 to 18 years). Time since
diagnosis of type 2 diabetes was obtained from the patient database, and was
measured in years. Duration of diabetes in this sample ranged from 1 to 47 years (M =
14.84; S.D. = 9.28). Means for BMI and abdominal circumference were well above
recommended limits. Adults are considered overweight with a BMI between 25 and 30,
and are considered obese with a BMI over 30. According to those guidelines, the BMI
data for this sample indicates that 7.4% were of normal weight, 22.1% were overweight,
and 70.6% were obese. National Heart Lung and Blood Institute guidelines state that
abdominal circumference has some predictive value of disease beyond that of BMI, but
not when BMI is over 35. In this sample only one participant had an abdominal
circumference under 35. The target blood pressure range for people with diabetes is
<130/80 mmHg (American Diabetes Association, 2003). In this sample, the systolic
goal was met by 31.9%, and the combined systolic/diastolic goal was met by 20.3% of
individuals.
American Diabetes Association standards of care indicate a target HbA1c of <
7% for people with diabetes (American Diabetes Association, 2006), a goal met by 27%
of the sample in which it was measured (n = 63). Applying the cardiovascular risk level
cutpoints for high sensitivity CRP (hs-CRP) test results (Pearson et al., 2003) to the
sample data reveals that 28.2% fall in the range corresponding to low to average risk (<

25
1.0 mg/L to 3.0 mg/L), 40.8% are in the high risk range (> 3.0 mg/L to 10 mg/L), and
31% have markedly high hs-CRP levels (> 10 mg/L). Reference ranges for IL-6 could
not be obtained.
Table 1
Demographic, biomedical, and psychological screening characteristics of the sample.
Variable

Frequency

Percentage

62
9

87.3
12.7

67
4

94.4
5.6

Mean

S.D.

Minimum

Maximum

Age (yrs)
Education (yrs)

67.06
11.30

5.00
2.57

60
5

80
18

Duration of diabetes (yrs)
BMI
Abdominal circumference (in)
BP Systolic
BP Diastolic
HbA1c
Interleukin-6 (pg/mL)
C-reactive protein (mg/L)

14.84
33.52
46.57
137.67
83.88
8.17
4.01
8.83

9.28
6.28
5.32
21.83
13.82
1.97
5.94
8.65

1
20.60
34
100
50
5.60
.58
.08

47
49.70
59
220
120
14.60
40.00
46.41

GDS
3MS
NAART
Predicted WAIS-R
Vocabulary Scaled Score

4.20
87.07
12.40

3.74
6.15
8.59

0
71
1

18
100
35

8.38

1.77

5.25

13

Sex
Female
Male
Handedness
Right
Left

According to the cutoff scores issued for the 30-item form of the Geriatric
Depression Scale (GDS), normal range is 0 to 9, mild depression is 10 to 19, and
severe depression is 20 to 30 (Yesavage et al., 1982). By these criteria, 88.7% of
participants in the sample fell in the normal range, and 11.3% fell in the mildly
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depressed range. Participants with a GDS score higher than 19 were excluded from the
study.
A cutoff score of 70 on the Modified Mini-Mental State Examination (3MS) was
used to exclude participants from the study. The 3MS scores of the sample ranged
from 71 to 100 (M = 87.07; S.D. = 6.15). 3MS normative data for older adult African
Americans is available (Brown, Schinka, Mortimer, & Graves, 2003) stratifying data by
sex, age (60-71 or 73-84), and education (< 12, 12, or > 12 years). Given that cell sizes
were small at the two higher education ranges (as low as n = 2), data from the present
sample were compared to normative data using only sex and age range. Using these
criteria, 91.6% of the sample (n = 65) had a 3MS score within 1.5 standard deviations of
the age and sex appropriate normative data. Only 4.2% of the sample (n = 3) scored
more than 2 standard deviations above the published norms; those scores were above
our cutoff, at 74 and 75.
The North American Adult Reading Test (NAART) scores for the sample ranged
from 1 to 35 (M = 12.40; S.D. = 8.59). NAART performance is reportedly correlated with
education and social class, but not with age, gender, or ethnicity (Strauss, Sherman, &
Spreen, 2006). Using NAART scores predicted based solely on age and education
(Uttl, 2002) produced predicted scores that were an average of 19.45 raw score points
higher than the observed scores from this sample of participants. Thus, it may be that
social class, which is not accounted for by this prediction equation, is a robust predictor
of NAART performance in this sample. Using an equation designed to predict WAIS-R
Vocabulary subtest scores based on NAART score and years of education (Uttl, 2002)
yielded scaled scores ranging from 5.25 to 13 (M = 8.38; S.D. = 1.77).
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Descriptive statistics for neuropsychological outcome measures are shown in Table 2.
Examination of the standardized scores reveals that mean scores for most
neuropsychological tests fell in the average range or higher. Exceptions included: 1)
SDMT Written and SDMT Oral, which fell in the mildly impaired range, 2) CVLT-II Short
Delay Free Recall, Long Delay Free Recall, and Long Delay Semantic Clustering, all of
which were in the low average range, and 3) Grooved Pegboard, which was in the low
average range for both hands. Mean scores for a sample with such a wide range of
ages and reading levels, however, may fail to adequately characterize performance
levels. To address this concern, Table 3 displays the percentage of participants falling
into specific z-score ranges for the neuropsychological measures in the study purported
to tap executive functions. Examination of this table reveals that across tests, the
percentage of participants falling more than one standard deviation below the norm
ranged from 17.6 to 67.6 percent. Based on the percentage of scores falling at least
one standard deviation below the mean on this group of measures, participants in this
sample appear to have performed best on Semantic Fluency (on which only 2.8% of the
sample more than 1 S.D. below the mean score), followed by Phonemic Fluency (21.3%
averaged across CFL and FAS), Stroop Color-Word (27.4%), Trail Making Test Part B
(39.4%), SDMT Written (62.0 %), and SDMT Oral (67.6%). Table 4 displays the
percentage of participants falling into specific z-score ranges for relevant indices on the
administered measures of verbal memory. The distributions across the z-score range in
this table indicates that the participants in this sample performed best on Logical
Memory Immediate and Delayed Recall (both of which were associated with 11.3% of
the sample scoring more than 1 S.D. below the norm), followed by scores from the
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Table 2
Descriptive statistics for neuropsychological outcome measures.

Measure

n

Mean

S.D.

Standardized
Score

S.D.

Stroop Color-Word

69

21.06

10.61

9.57

3.45

Trail Making Test Part B

71

209.28

87.44

8.37

3.45

Semantic Fluency
Animal Naming
Boys Names

71
36
35

14.65
14.83
14.46

4.17
3.29
4.96

-11.12
--

-2.54
--

Phonemic Fluency
CFL
FAS

71
36
35

26.38
26.11
26.66

11.08
11.50
10.79

-8.90
48.41

-3.04
9.26

Symbol Digit Modalities Test
Written
Oral

71
71

26.21
30.80

12.03
12.62

-1.39
-1.49

1.34
1.22

WAIS-III Digit Span Total
Digits Forward
Digits Backward

70
70
70

12.31
7.96
4.36

3.13
1.98
1.68

46.49
---

6.93
---

CVLT-II
Short Delay Free Recall
Short Delay Semantic Clustering
Long Delay Free Recall
Long Delay Semantic Clustering

71
71
71
71

6.77
.79
8.61
.96

2.90
1.39
3.17
1.40

-.85
-.63
-.96
-.72

.94
1.01
.78
.61

WMS-III Logical Memory
Immediate Recall
Delayed Recall

71
71

32.45
18.39

9.85
7.12

53.31
56.58

12.36
12.96

Grooved Pegboard
Dominant
Non-dominant

70
70

130.40
161.03

55.42
66.88

42.26
40.91

8.95
10.51

Boston Naming Test

71

39.94

9.44

9.10

2.92

Judgment of Line Orientation 15-item

70

7.91

3.53

--

--
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Table 3
Percentage of participants within specified z-score ranges on executive function
measures.
Standard
deviation
from the mean
+3.0 to +2.0
+1.99 to +1.0
+.99 to 0
–.01 to –1.0
–1.01 to –2.0
–2.01 to –3.0

Stroop
CW

Trails B

Semantic
Fluency Animals

4.3
8.7
42.0
27.5
14.5
2.9

1.4
11.3
28.2
19.7
35.2
4.2

5.6
19.4
50.0
22.2
2.8
0.0

Phonemic
Fluency
CFL

Phonemic
Fluency
FAS

SDMT
Written

SDMT
Oral

0.0
11.1
33.3
30.6
22.2
2.8

2.9
5.9
32.4
41.2
17.6
0.0

0.0
2.8
12.7
22.5
26.8
35.2

0.0
1.4
7.0
23.9
36.6
31.0

Table 4
Percentages of participants within specified z-score ranges on verbal memory
measures.

Standard
deviation
from the mean

CVLT-II
Short Delay
Free Recall

CVLT-II
SDFR
Semantic
Clustering

CVLT-II
Long Delay
Free Recall

CVLT-II
LDFR
Semantic
Clustering

Logical
Memory
Immediate
Recall

Logical
Memory
Delayed
Recall

+3.0 to +2.0
+1.99 to +1.0
+.99 to 0
–.01 to –1.0
–1.01 to –2.0
–2.01 to –3.0

0.0
7.0
22.5
35.2
29.6
5.6

0.0
4.2
22.5
49.3
23.9
0.0

1.4
1.4
23.9
40.8
25.4
7.0

0.0
4.2
11.3
70.4
14.1
0.0

7.0
28.2
29.6
23.9
8.5
2.8

16.9
28.2
29.6
14.1
8.5
2.8

CVLT-II: Semantic Clustering – Long Delay Free Recall (14.1%), Semantic Clustering –
Short Delay Free Recall (23.9%), Long Delay Free Recall (32.4%), and Short Delay
Free Recall (35.2).
Regression analyses
Executive functions. Results for the series of hierarchical multiple regression
analyses examining the relationship between HbA1c, IL-6, CRP, and executive
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functions are shown in Table 5. Overall, the predictors accounted for a significant
proportion of the variance in the Stroop Color-Word test, Trail Making Test Part B, and
Semantic Fluency. For both the Written and Oral versions of the Symbol Digit
Modalities Test, the regression equation approached significance for HbA1c only. The
regression equation for Phonemic Fluency did not reach significance.
For Stroop Color-Word, the full model accounted for a statistically significant
proportion of the variation in the dependent measure, R2 = 30.2%, F(5,55) = 4.76, p <
.01. HbA1c accounted for no additional variance in the dependent measure above the
covariates, ∆F(1,57) = .014, p < .91. The addition of the two inflammatory markers to
the model accounted for an additional 8.0% of the variance, ∆F(2,55) = 3.17, p < .05.
Among the inflammatory markers, only CRP made a significant unique contribution to
the final model, t(1,55) = 2.46, p < .02, sr2 = 7.7%, indicating that higher levels of CRP
were associated with higher numbers of correct responses on Stroop Color-Word.
For Trail Making Test Part B, the full model accounted for a statistically
significant portion of the variation in the dependent measure, R2 = 41.0%, F(5,56) =
7.79, p < .01. The addition of HbA1c to the equation accounted for an additional 6.3%
of the variance above the covariates, ∆F(1,58) = 5.88, p < .02, indicating that higher
levels of HbA1c were associated with longer times to complete the Trails B task. IL-6
and CRP accounted for an additional 2.9% of the variance in the dependent variable,
although the change was not significant, ∆F(2,56) = 1.37, p = .26.
For Semantic Fluency, the full model accounted for a statistically significant
portion of the variance in the dependent measure, R2 = 33.8%, F(5,56) = 5.72, p < .01.
HbA1c accounted for no additional variance in the dependent measure above the
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Table 5
Hierarchical regression analyses of glycated hemoglobin, inflammatory markers, and
cognitive measures tapping executive functions.

Criterion Variables

Step

Stroop Color-Word

1
2
3

Trail Making Test Part B

1
2
3

Semantic Fluency

1
2
3

Phonemic Fluency

1
2
3

Symbol Digit Modalities - Written

1
2
3

Symbol Digit Modalities - Oral

1
2
3

†p

< .10; *p < .05; **p < .01

Predictor
Variables

Full Model
∃

Age
NAART
HbA1c
IL6
CRP

-.45**
.06
-.01
-.02
.29*

Age
NAART
HbA1c
IL6
CRP

.44**
-.38
.26*
.07
-.18

Age
NAART
HbA1c
IL6
CRP

-.46**
.20†
.02
.27*
.16

Age
NAART
HbA1c
IL6
CRP

-.25*
.51**
.11
-.05
.21†

Age
NAART
HbA1c
IL6
CRP

-.41**
.29*
-.21†
-.02
.21†

Age
NAART
HbA1c
IL6
CRP

-.40**
.29*
-.21†
-.07
.20

R2

∆R2

.22**
.00
.08*

.32**
.06*
.03
.22**
.00
.12*
.37**
.01
.04
.23**
.04†
.04
.24**
.04†
.04
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covariates, ∆F(1,58) = .007, p < .94. The addition of the two inflammatory markers to
the model accounted for an additional 8.0% of the variance, ∆F (2,56) = 4.86, p < .05.
Among the inflammatory markers, only IL-6 made a significant unique contribution to the
final model, t(1,56) = 2.30, p < .03, sr2= 6.3%, indicating that higher levels of IL-6 were
associated with greater numbers of correct semantic fluency responses.
For the Symbol Digit Modalities Test - Written version, the full model accounted
for a statistically significant portion of the variance in the dependent measure, R2 =
31.6%, F(5,56) = 5.18, p < .001. The addition of HbA1c to the model accounted for an
additional 4.0% of the variance above the covariates, a change that approached
significance, ∆F(1,58) = 3.23, p = .08. An additional 4.1% of the variance in the
dependent variable was accounted for by adding IL-6 and CRP to the model, although
the change was not significant, ∆F(2,56) = 1.69, p = .19. Among the individual
predictors, contributions to the final model that approached significance were made by
HbA1c (as described above) and CRP, t(1,56) = 1.81, p = .08, sr2= 4.0%.
For the Symbol Digit Modalities Test – Oral version, the full model accounted for
a statistically significant portion of the variance in the dependent measure, R2 = 31.3%,
F(5,56) = 5.11, p < .001. The addition of HbA1c to the model accounted for an
additional 4.2% of the variance in the dependent variable above the covariates, a
change that approached significance, ∆F(1,58) = 3.34, p = .07. Adding IL-6 and CRP to
the model accounted for an additional 3.5% of the variance, although this change was
not significant, ∆F(2,56) = 1.42, p = .25.
For Phonemic Fluency, the full model accounted for a statistically significant
portion of the variance in the dependent measure, R2 = 42.4%, F(5,56) = 8.26, p < .001.
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The addition of HbA1c to the equation accounted for an additional 1.0% of the variance
above the covariates, a change that was not statistically significant, ∆F(1,58) = .93, p =
.34. Adding IL-6 and CRP to the model accounted for an additional 4.1% of the
variance, although this change was not statistically significant, ∆F(2,56) = 1.98, p = .15.
Among the inflammatory markers, only CRP made a contribution to the final model that
approached significance, t(1,56) = 1.98, p = .052, sr2 = 4.0%.
Verbal memory. Results for the series of hierarchical multiple regression
analyses examining the relationship between HbA1c, IL-6, CRP, and verbal memory are
shown in Table 6. Overall, the regression equations accounted for significant amounts
of the variance in CVLT-II Semantic Clustering – Short Delay Free Recall, CVLT-2 Long
Delay Free Recall, and Logical Memory – Delayed Recall. For CVLT-II Short Delay
Free Recall and Logical Memory – Immediate Recall, the variance accounted for by the
regression equation approached significance. The regression equation for CVLT-II
Semantic Clustering – Long Delay Free Recall did not reach significance.
For CVLT-II Semantic Clustering – Short Delay Free Recall, the full model
accounted for a statistically significant amount of the variance in the dependent
measure, R2 = 20.2%, F(5,56) = 2.84, p < .02. The addition of HbA1c to the model
accounted for an additional 6.5% of the variance in the dependent variable above the
covariates, ∆F(1,58) = 4.71, p < .03, indicating that higher levels of HbA1c were
associated with reduced use of the semantic clustering strategy. IL-6 and CRP
accounted for no additional variance in the dependent measure, R2 = .20%, ∆F(1,58) =
4.71, p < .03.
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Table 6
Hierarchical regression analyses of glycated hemoglobin, inflammatory markers, and
verbal memory measures.

Criterion Variables
CVLT-II Short Delay Free Recall

Step
1
2
3

CVLT-II Short Delay Free Recall
Semantic Clustering

1
2
3

CVLT-II Long Delay Free Recall

1
2
3

CVLT-II Long Delay Free Recall
Semantic Clustering

1
2
3

Logical Memory Immediate Recall

1
2
3

Logical Memory Delayed Recall

1
2
3

†p

< .10; *p < .05; **p < .01

Predictor
Variables

Full Model
∃

Age
NAART
HbA1c
IL6
CRP

-.14
.12
-.31*
-.22†
.20

Age
NAART
HbA1c
IL6
CRP

-.02
.37**
-.27*
-.04
.03

Age
NAART
HbA1c
IL6
CRP

-.25†
.15
-.17
-.21
.19

Age
NAART
HbA1c
IL6
CRP

.02
.20
-.23†
-.17
.10

Age
NAART
HbA1c
IL6
CRP

-.18
.33*
-.15
-.09
.07

Age
NAART
HbA1c
IL6
CRP

-.11
.30*
-.21
-.17
.17

R2

∆R2

.02
.09*
.06

.14*
.07*
.00
.10*
.03
.06
.04
.05†
.03
.14**
.02
.01
.10*
.04
.04
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For CVLT-2 Long Delay Free Recall, the full model accounted for a statistically
significant amount of the variance in the dependent measure, R2 = 17.8%, F(5,56) =
2.43, p < .05. Adding HbA1c to the model did not account for a statistically significant
amount of the variance in the dependent variable above the covariates, ∆R2 = 2.5%, ∆F
(1,58) = 1.62, p = .21. The addition of IL-6 and CRP to the model also did not account
for a significant amount of the variance in the dependent variable, ∆R2 = 5.7%, ∆F(2,56)
= 1.95, p = .15.
For Logical Memory – Delayed Recall, the full model accounted for a statistically
significant amount of the variance in the dependent measure, R2 = 18.2%, F(5,56) =
2.48, p < .04. Adding HbA1c to the model did not account for a statistically significant
amount of the variance in the dependent variable above the covariates, ∆R2 = 3.9%,
∆F(1,58) = 2.62, p = .11. The addition of IL-6 and CRP to the model also did not
account for a significant amount of the variance in the dependent variable, ∆R2 = 4.1%,
∆F (2,56) = 1.41, p = .25.
For CVLT-II Short Delay Free Recall, the full model accounted for a portion of the
variance in the dependent measure that approached significance, R2 = 17.3%, F(5,56) =
2.34, p = .053. Adding HbA1c to the model accounted for a statistically significant
amount of the variance in the dependent variable above the covariates, ∆R2 = 8.8%, ∆F
(1,58) = 5.76, p < .02, indicating that higher levels of HbA1c was associated with fewer
words recalled. The addition of IL-6 and CRP to the model did not account for a
significant amount of the variance in the dependent variable, ∆R2 = 6.3%, ∆F(2,56) =
2.12, p = .13. Among the inflammatory markers, only IL-6 made a contribution to the
final model that approached significance, t(1,56) = -1.71, p = .09, sr2 = 4.3%.
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For Logical Memory – Immediate Recall, the full model accounted for a portion of
the variance in the dependent measure that approached significance, R2 = 17.5%,
F(5,56) = 2.37, p = .051. Adding HbA1c to the model did not account for a statistically
significant amount of the variance in the dependent variable above the covariates, ∆R2 =
2.1%, ∆F(1,58) = 1.48, p = .23. The addition of IL-6 and CRP to the model also did not
account for a significant amount of the variance in the dependent variable, ∆R2 = 1.0%,
∆F(2,56) = .33, p = .72.
For CVLT-II Semantic Clustering – Long Delay Free Recall, the full model did not
account for a statistically significant amount of the variance in the dependent variable,
R2 = 11.5%, F(5,56) = 1.45, p = .22. The addition of HbA1c to the model accounted for
a portion of the variance in the dependent variable above the covariates that
approached significance, ∆R2 = 4.9%, ∆F (1,58) = 1.48, p = .08. Adding IL-6 and CRP
to the equation did not add significantly to the variance accounted for in the dependent
variable, ∆R2 = 2.9%, ∆F(2,56) = .92, p = .41.
Attention, language, visuospatial judgment, and fine motor dexterity. Results for
the series of hierarchical multiple regression analyses examining the relationship
between HbA1c, IL-6, CRP, and the array of neuropsychological measures measuring
attention, language, visuospatial judgment, and fine motor dexterity are shown in Table
7. Overall, the regression equations accounted for significant amounts of the
variance in Digits Forward, Digits Backward, Boston Naming, and Grooved Pegboard
for both Dominant and Non-dominant hands. The regression equation for Judgment of
Line Orientation did not reach significance.
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Table 7
Hierarchical regression analyses of glycated hemoglobin, inflammatory markers, and
cognitive function measures.

Criterion Variables
Digits Forward

Step
1
2
3

Digits Backward

1
2
3

Boston Naming

1
2
3

Judgment of Line Orientation

1
2
3

Grooved Pegboard - Dominant

1
2
3

Grooved Pegboard – Non-dominant

1
2
3

†p

< .10; *p < .05; **p < .01

Predictor
Variables

Full Model
∃

Age
NAART
HbA1c
IL6
CRP

-.30*
.30
-.06
.07
.03

Age
NAART
HbA1c
IL6
CRP

-.21†
.49**
-.01
-.04
.06

Age
NAART
HbA1c
IL6
CRP

-.19
.46**
-.11
-.07
.19

Age
NAART
HbA1c
IL6
CRP

-.18
.20
-.16
-.16
.07

Age
NAART
HbA1c
IL6
CRP

.32*
-.04
.15
.31*
-.23†

Age
NAART
HbA1c
IL6
CRP

-.11
.30*
-.21
-.17
.17

R2

∆R2

.19**
.00
.01
.32**
.00
.00
.25**
.01
.03
.08†
.02
.02
.13**
.02
.11*
.16**
.06*
.08*
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For Digits Forward, the full model accounted for a statistically significant amount
of the variance in the dependent measure, R2 = 20.1%, F(5,56) = 2.82, p < .02. No
additional variance above the covariates was accounted for by the addition of HBA1c,
∆R2 = .30%, ∆F(1,58) = .20, p = .65, or the inflammatory markers IL-6 and CRP, ∆R2 =
.50%, ∆F(2,56) = .17, p = .84.
For Digits Backward, the full model accounted for a statistically significant
amount of the variance in the dependent measure, R2 = 32.3%, F(5,56) = 5.35, p <
.001. No additional variance above the covariates was accounted for by the addition of
HBA1c, ∆F(1,58) = .003, p = .96, or the inflammatory markers IL-6 and CRP, ∆R2 =
.40%, ∆F(2,56) = .15, p = .86.
For Boston Naming, the full model accounted for a statistically significant amount
of the variance in the dependent measure, R2 = 29.8%, F(5,56) = 4.74, p < .001. No
additional statistically significant variance above the covariates was accounted for by
the addition of HBA1c, ∆R2 = 1.2%, ∆F(1,58) = .91, p = .34, or the inflammatory markers
IL-6 and CRP, ∆R2 = 3.2%, ∆F(2,56) = 1.29, p = .28.
For Grooved Pegboard – Dominant Hand, the full model accounted for a
statistically significant amount of the variance in the dependent measure, R2 = 25.5%,
F(5,56) = 3.83, p < .005. The additional variance above the covariates accounted for by
the addition of HbA1c was not statistically significant, ∆R2 = 2.0%, ∆F (1,58) = 1.35, p =
.25. Adding IL-6 and CRP to the equation accounted for a statistically significant
amount of variance in the dependent variable above that contributed by the covariates,
∆R2 = 10.7%, ∆F(2,56) = 4.02, p < .02. Among the inflammatory markers, IL-6 made a
unique and statistically significant contribution to the variance in the final model, t(1,56)
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= 2.54, p < .01, sr2 = 8.6%, indicating that higher levels of IL-6 were associated with
longer time to completion on Grooved Pegboard – Dominant. The unique contribution
of CRP to the final model approached significance, t(1,56) = -1.91, p = .062, sr2 = 4.8%.
For Grooved Pegboard – Non-dominant Hand, the full model accounted for a
statistically significant amount of the variance in the dependent measure, R2 = 29.9%,
F(5,56) = 4.78, p < .001. HbA1c accounted for 5.9% of additional variance in the
dependent measure above the covariates, ∆F(1,58) = 4.39, p < .04. Adding IL-6 and
CRP to the model accounted for an additional 8.2% of the variance in the dependent
variable, ∆F(2,56) = 3.27, p < .045. Among the inflammatory markers, only IL-6 made a
unique and statistically significant contribution to the variance in the model, t(1,56) =
2.39, p < .02, sr2 = 3.0%, indicating that higher levels of IL-6 were associated with
longer time to completion on Grooved Pegboard – Non-dominant.
For Judgment of Line Orientation, the full model did not account for a statistically
significant amount of the variance in the dependent variable, R2 = 12.9%, F(5,56) =
1.66, p = .16. No additional statistically significant variance above the covariates was
accounted for by the addition of HBA1c, ∆R2 = 2.3%, ∆F(1,58) = 1.48, p = .23, or the
inflammatory markers IL-6 and CRP, ∆R2 = 2.3%, ∆F(2,56) = .724, p = .49.
Further exploratory analyses
The following analyses were conducted in order to determine whether any
additional information could be obtained that could aid in the interpretation the results
that have been presented. These analyses must be considered exploratory, however,
because removing cases or adding variables to these analyses results in a reduction in
the power to detect effects. The previous analyses employed six variables and thus had
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already reached the power limits for this design and sample size (Field, 2005).
Nonetheless, the following analyses were conducted in order to determine whether any
effects were present that were large enough to be detected under these limited
circumstances.
Investigation of CRP effects. In the original analyses, the results indicated that
higher levels of CRP were associated with improved cognitive performance. In order to
further examine the direction of the relationship between CRP and cognitive
performance, the cases with the highest levels of CRP (> 10mg/L; n = 22) were
removed and the original analyses were performed again. This modification of the
sample yielded a change in the direction of the relationship between CRP and cognition
for all relevant criterion variables, such that higher levels of CRP were associated with
worse performance on Stroop Color-Word, Semantic Fluency, Phonemic Fluency, and
Symbol Digit Modalities – Written version. This result is suggestive of a U-shaped
function in which very high levels of CRP (< 10 mg/L) are associated with improved
performance on the cognitive measures tapping executive functions, whereas for those
patients with levels of CRP falling in the low to high risk range, higher levels of CRP are
associated with poorer executive function performance.
Relationship with other covariates: Depression and duration of diabetes. In order
to determine whether depression accounted for any of the variance in the criterion
variables, all of the original regression analyses were re-run with GDS score entered as
a covariate at the second step. GDS score did not contribute significantly to the
variance in the model either at the second step or in the final model for any of the
measures of executive function or verbal memory, nor did it change any of the patterns
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of effects already reported. Among the remaining neuropsychological criterion
variables, the addition of GDS was significant only for Digits Backward. Specifically, the
full model accounted for 41.1% of the variance in the dependent variable, F(6,55) =
6.39, p < .001, as compared with 32.3% for the same model without GDS included.
Adding GDS to the model accounted for an additional 8.2% of variance above that
contributed by the covariates, ∆F(1,58) = 7.98, p < .006. GDS made a unique and
statistically significant contribution to the variance in the full model, t(1,55) = 2.86, p <
.005, sr2 = 3.0%, indicating that higher scores on the GDS were associated with
improved Digits Backward performance.
In order to determine whether duration of diabetes accounted for any of the
variance in the criterion variables, all of the original regression analyses were re-run
with duration of diabetes entered as a covariate at the second step. The rationale for
entering duration of diabetes before HbA1c is that duration might be associated with
long-term neurological changes (Awad et al., 2004), whereas HbA1c may have a
relatively transient effect on cognition in comparison. Duration of diabetes did not
contribute significantly to the variance in the dependent variable for any of the measures
of executive function. Among measures of verbal memory, duration of diabetes made
significant contributions to the models for CVLT-II Short Delay Free Recall and Logical
Memory Immediate Recall. Duration of diabetes also contributed significantly to the
variance in the model for the Boston Naming Test.
For CVLT-II Short Delay Free Recall, the full model accounted for 21.9% of the
variance in the dependent variable, F(6,55) = 2.58, p < .03, an increase of 4.6% over
the same model without duration of diagnosis, and a shift to statistical significance. The
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addition of duration of diabetes to the model accounted for an additional 9.5% of the
variance in the dependent variable above the covariates, ∆F(1,58) = 4.26, p < .01.
Whereas HbA1c was statistically significant and IL-6 approached significance in the
previous model, those effects were eliminated with the addition of duration of diabetes.
For Logical Memory Immediate Recall, the full model accounted for 24.0% of the
variance in the dependent variable F(6,55) = 2.90, p < .02, an increase of 6.5% over the
same model without duration of diabetes. The addition of duration of diabetes to the
model accounted for an additional 8.1% of the variance in the dependent variable above
the covariates, ∆F(1,58) = 6.05, p < .02. As in the model without duration of diabetes,
however, no additional variance above the covariates was contributed by adding
HbA1c, IL-6 and CRP to the model.
For the Boston Naming Test, with duration of diabetes included, the full model
accounted for 33.9% of the variance in the dependent variable, F(6,55) = 4.70, p < .001.
The addition of duration of diabetes to the model accounted for an additional 5.3% of
the variance in the dependent variable above the covariates, ∆F(1,58) = 8.57, p < .001.
As in the previous model without duration of diabetes, the addition of HbA1c, IL-6 and
CRP to the model did not account for a statistically significant amount of variance in the
dependent variable above the covariates. In the final model, the contribution to the
model made by duration of diagnosis only approached significance, t(1,55) = -1.86, p =
.07, sr2 = 4.1%.
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CHAPTER 4: DISCUSSION
The elderly African Americans with type 2 diabetes who served as participants in
this study generally performed in the average range on neuropsychological measures.
There were some exceptions, though. Participants were mildly impaired on both the
written and oral versions of the Symbol Digit Modalities test, demonstrated low average
performance on three of the CVLT-II scores (Short and Long Delay Free Recall, and
Long Delay Semantic Clustering), and low average performance on Grooved Pegboard
for both hands. Thus, these results provide partial support for the hypothesis that these
participants would be impaired in some aspects of executive function and on measures
of verbal memory that require intact executive functions for adequate performance.
Mean scores for all other executive function measures were in the average range,
however, which is inconsistent with that hypothesis. The low average performances on
the CVLT-II are consistent with the hypothesis, but this low average range was not
significantly different from average.
The findings of the present study are consistent with the hypothesis that chronic
hyperglycemia would be inversely related to performance on measures of executive
function and verbal memory that tap executive functions, but not to other
neuropsychological measures. Higher HbA1c scores were significantly associated with
poorer performance on Trail Making Test Part B, CVLT-II Short Delay Free Recall, and
CVLT-II Semantic Clustering – Short Delay Free Recall, and approached significance in
predicting poorer performance on Symbol Digit Modalities Test – Written and Oral
versions, and CVLT-II Semantic Clustering – Long Delay Free Recall.
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The observed association between higher HbA1c and impaired performance on a
word list learning task is consistent with previous findings (Gradman et al., 1993;
Jagusch, Cramon, Renner, & Hepp, 1992; Perlmuter et al., 1984; Reaven et al., 1990),
and extends the previous findings by demonstrating a similar effect in an elderly African
American sample. A few studies have reported no significant relationship between
HbA1c and word list learning. For example, Lowe and colleagues (Lowe et al., 1994)
employed another widely used word list learning test, the Rey Auditory Verbal Learning
Test (RAVLT), and found no group differences between diabetics and controls. Their
sample consisted of Native Americans, however, and was younger, ranging in age from
45 to 75 years old. Zaslavsky and colleagues (Zaslavsky, Gross, Chaves, & Machado,
1995) employed a word list learning task that, similar to the CVLT-II, involved the five
auditory presentations of a word list. Unlike the CVLT-II, however, the task used by
Zaslavsky and colleagues entailed free recall trials occurring only after the first and fifth
list presentations, and then again after a 15-minute interval. In contrast, the CVLT-II
consists of free recall trials occurring following each of the five list presentations, and
then again after a brief delay and a longer, 20-minute interval. Thus, the encoding
process for the word list-learning task used by Zaslavsky and colleagues may be
qualitatively different that that engaged in during CVLT-II. Specifically, the CVLT-II
offers many more opportunities to reinforce the learning of the list words than does the
other task. No other information was provided about the types of words in the lists used
by Zaslavsky and colleagues or their semantic relationships, which also may have
accounted for some of the difference in the outcomes.
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In the present study chronic hyperglycemia and inflammation were not
significantly associated with immediate or delayed recall performance on a paragraph
recall task. This result is inconsistent with those of a previous study in which
experimentally-induced acute hyperglycemia was associated with a relative decline in
recall on an auditory-verbal paragraph recall task (Greenwood et al., 2003). There may
be differences in the relative influence on cognitive function of acute versus chronic
hyperglycemia, however. It may be that those individuals in the present study with
higher acute glucose levels performed more poorly on this task, but this could not be
determined because acute glucose levels were not measured. The present results do
support a relationship between duration of diagnosis (i.e., the effects of long-term
chronic hyperglycemia) and verbal learning and memory decrements, however.
Specifically, longer duration of diabetes diagnosis was associated with poorer
immediate recall performance both on a paragraph recall task and on a verbal word listlearning task. This result is similar to those in a previous study (Elias et al., 1997) in
which impaired immediate and delayed word list-learning were related to duration of
diabetes diagnosis. Further, in the present study there was a trend toward an
association between longer duration of diagnosis and poorer performance on a
confrontation picture-naming task that relies heavily upon intact semantic retrieval
abilities. These deficits are similar to the classic pattern of cognitive impairment
observed in dementia of the Alzheimer’s type, which involves rapid forgetting and
impaired semantic retrieval (Wicklund, Johnson, Rademaker, Weitner, & Weintraub,
2006). It is unclear whether diabetes increases the risk of Alzheimer’s disease
(Arvanitakis, Wilson, Bienias, Evans, & Bennett, 2004) or not (Akomolafe et al., 2006),
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but the present results suggest that those with a longer duration of diagnosis are more
likely to manifest a pattern of cognitive performance that is similar to that found among
individuals with dementia of the Alzheimer’s type.
The present finding of the association between higher HbA1c and impaired Trails
B performance is consistent with the results of one previous study (Reaven, 1991) in
which HbA1c was inversely related to Trails B performance in both a group of 29 elderly
type 2 diabetes patients, and in the group of 30 demographically similar, healthy
controls. This finding is inconsistent with the results of several other studies, however.
For example, in one study, 50 Caucasian and African American adults with type 2
diabetes and 50 demographically similar, healthy controls failed to differ on Trails B
after controlling for age, sex, race, and estimated IQ (Ryan & Geckle, 2000a). Notably,
however, the participants were mostly middle-aged, ranging in age from 34 to 65 (M =
50.8). In another study, elderly type 2 diabetics and controls did not differ on Trails B
(Helkala, Niskanen, Viinamaki, Partanen, & Uusitupa, 1995). The group sizes were
relatively small, however, (ns = 20 and 22, respectively), and they used means
comparisons instead of regressions, and thus, could not control for the effects of age
and education. In sum, it may be that Trails B performance varies with HbA1c levels in
elderly adults, but sufficiently large sample sizes and appropriate statistical methods are
required in order to observe this effect.
This is the first study to examine the effects of inflammation and chronic
hyperglycemia in a group comprised solely of adults with type 2 diabetes. Zero-order
correlations between glycated hemoglobin and inflammation indicated that HbA1c was
not related to either IL-6 (r = -.08; p = .53) or CRP (r = .00; p = .99). This result may
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have been an artifact of the study methods, however, given that in most cases HbA1c
and the inflammatory markers were measured on different days. Thus, it is possible
(although unclear from the literature) that HbA1c is typically more highly related with the
inflammatory markers. Notably, the inflammatory markers were also not highly
correlated with each other (r = .26, p < .04). The fact that these predictors had so little
statistical relationship to each other suggested that different patterns of effects for
HbA1c and each of the inflammatory markers might be expected. Indeed, there was
very little overlap in the effects of the three predictor variables. Higher IL-6 significantly
predicted slower completion times on Grooved Pegboard – Dominant hand, but also
was associated with a greater number of correct responses on Semantic Fluency; IL-6
approached significance in predicting poorer performance on CVLT-II Short Delay Free
Recall. CRP was unique among the predictor variables in this study in that, contrary to
the study hypothesis, higher CRP levels were associated with improved cognitive
performance. Specifically, higher CRP was significantly associated with better
performance on Stroop Color-Word, and approached significance in predicting better
performance on Phonemic Fluency, Symbol Digit Modalities – Written version, and
Grooved Pegboard – Dominant hand. This finding is inconsistent with the majority of
the literature, which tends to show an inverse relationship between CRP and cognition
(Engelhart et al., 2004; Schmidt et al., 2002; Teunissen et al., 2003; Yaffe et al., 2004;
Yaffe et al., 2003). One study, however, showed that in older adults with the APOE4
allele, higher CRP was associated with lower rates of dementia and cognitive
impairment without dementia, whereas in a control group without the APOE4 allele,
higher CRP was associated with increased rates of dementia and cognitive impairment
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without dementia (Haan, Aiello, West, & Jagust, 2007). Further, in those without the
APOE4 allele, CRP was significantly lower. They interpreted the results as suggesting
that in those with APOE4, high CRP may be a marker of better immune function,
leading to reduced rates of dementia and Alzheimer’s disease. In the present study, an
exploratory analysis was conducted in which the cases with the highest levels of CRP
were removed from the analyses. Results showed that with the CRP levels in the
analysis reduced to the range of low to high risk only, the direction of the relationship
reversed between CRP and several of the criterion variables--particularly executive
measures--such that CRP was inversely related to cognitive performance. This result
suggests that it was primarily those with very high CRP (> 10 mg/L) driving the effect of
higher CRP being related to improved performance on cognitive measures. APOE4
was not assessed in these participants (n = 22), but it seems unlikely that all of the
participants with the highest levels of CRP in this study had the APOE4 allele. It may
be, however, that higher CRP is associated with better cognitive functioning (possibly
via improved immune functioning) in some groups, including those with the APOE4
allele, and may be related to other as yet unknown factors, as well.
While the majority of studies of diabetes and cognition have used predominantly
or solely Caucasian samples, and a few had mixed-race samples (Ryan & Geckle,
2000a), this is the first study to examine the relationship between HbA1c and cognition
in a group of older adult African Americans with type 2 diabetes. One study examining
the relationships of HbA1c, blood pressure, and several other indicators of
cardiovascular risk in middle aged and older adult (43-82 years) African Americans
found that HbA1c was significantly related to better performance on Digits Forward, and
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marginally associated with better performance on an executive function screening
measure (Izquierdo-Porrera & Waldstein, 2002). This study differs from the present
study in several important ways, however, including the inclusion of middle aged
participants, a small sample size (n = 43), and the fact that only 19% of their sample
was diabetic. Another study employing a small sample (n = 43) of African American
adults found that a summary cardiovascular risk score was associated with increased
risk of impaired performance on a set of executive function tasks, but not on
visuospatial or memory tests (Pugh et al., 2003). The executive function tasks included
Trails B, Phonemic and Semantic Fluency, and Letter-Number Sequencing, while the
memory tests included Logical Memory Immediate and Delayed Recall, and a visual
memory task. Although only 12% (n = 5) of the sample had a self-reported diabetes
diagnosis, and the sample size was small, the findings of this study are consistent with
the present results, and provide additional evidence for the finding that in elderly African
Americans, cardiovascular risk factors are associated with impairments in executive
functions, but not contextual verbal memory.
Consistent with the study predictions, levels of HbA1c, IL-6, and CRP were not
significantly associated with performance on measures of visuospatial judgment,
language, simple auditory attention, or fine motor dexterity. Contrary to that prediction,
however, significant effects of the predictor variables were observed for Grooved
Pegboard, both for the Dominant and for the Non-dominant hand. The Grooved
Pegboard task has rarely been used in studies of older adults with type 2 diabetes, but
there is a small amount of evidence indicating that this population may have difficulty
with this task. For example, psychomotor slowing among middle aged diabetics has
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been reported, results that were based in part on impaired Grooved Pegboard
performance (Ryan & Geckle, 2000a). It was also demonstrated that improving glucose
regulation in a small group of elderly diabetics (n = 16) yielded improved performance
on a number of neuropsychological measures, including the Grooved Pegboard test
(Meneilly, Cheung, Tessier, Yakura, & Tuokko, 1993). The results of the present study
add to this small group of evidence suggestive of psychomotor slowing and/or reduced
fine motor dexterity in older adults with type 2 diabetes.
Digits Backward performance was not significantly impaired in this sample of
individuals with diabetes, nor was it significantly predicted by chronic hyperglycemia or
inflammation. Although Digits Backward, as a working memory test, is often grouped
with measures of executive function, it was not predicted to be impaired in this study
because it was not impaired in previous studies of cognitive function in older adults with
diabetes (Atiea, Moses, & Sinclair, 1995; Mooradian, Perryman, Fitten, Kavonian, &
Morley, 1988; Perlmuter, Tun, Sizer, McGlinchey, & Nathan, 1987; Reaven et al., 1990;
U'Ren et al., 1990) or who were deemed to be at high risk for diabetes (Vanhanen et al.,
1997). The failure to observe a significant effect of diabetes on this working memory
task may be attributable both to the difficulty of the task for older adults, and a restriction
in the range of scores for older adults. In other words, this task may be very difficult for
all adults in that age range. Thus, whether the comparison is made with healthy
controls or with published normative data, the performance of older adults with diabetes
appears to fall within the average range. Further, if most older adults correctly recall
very few digit strings on Digits Backward, the range of scores would be restricted,
reducing the correlation with other variables. A large sample size can increase the
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chances of detecting a small effect. The previous studies with null findings for Digits
Backward had diabetic sample sizes ranging from 29 to 43 participants. The fact that
no significant effects were detected for Digits Backward even with the larger sample in
the present study provides more evidence for the lack of association between
hyperglycemia and performance on this task. The present results also extend those
results to suggest a lack of association between Digit Span performance and
inflammation, as represented by levels of IL-6 and CRP. Notably, Digits Backward
performance was predicted by one variable in this study. Specifically, those with higher
scores on the depression screening measure (GDS) performed significantly better on
Digits Backward than those with lower GDS scores. Given that depression is a wellknown predictor of impaired cognitive functioning, particularly on measures such as
Digits Backward that require intact attentional and working memory abilities, this result
was unexpected. It should be noted however, that the majority of participants’ GDS
scores fell in the non-depressed range, and those with the highest scores fell in the
mildly depressed range (n = 5). Given that there were no moderately or severely
depressed individuals included in the sample, it may be that the mildly elevated GDS
scores and the higher Digits Backward scores were both reflective of effort.
Specifically, it is possible that those participants who were willing to admit to more
symptoms associated with depression may also have been more cooperative with the
testing process overall, and may have devoted more effort to testing, earning higher
scores on the challenging Digits Backward task.
There are several weaknesses in the present study that limit the generalizability
of the results. First, the sample size was relatively small. Unfortunately, relatively small
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sample sizes characterize much of the literature examining the relationships between
diabetes and cognition. A larger sample would have allowed for the detection of any
smaller effects that may have been present. Further, the relatively low number of
participants limited the number of variables that could be assessed in each analysis.
Thus, while some of the covariates that were measured may have accounted for a
statistically significant amount of additional variance in a larger sample, given the small
sample size there was not enough power to detect any additional effects related to
these additional variables. Having more participants would allow for the testing of more
complex models of the potential relationships between variables. While there were a
number of variables that were measured but not included in the study because of the
small sample size, there were still other variables that were not measured that may
have been informative. For instance, it would likely have been useful to have measures
of acute glucose levels, blood lipid levels, and current medications.
Another weakness of this study is the lack of a control group. Having a control
group would have allowed for the direct comparison of scores on cognitive measures
with a healthy, age- and education-matched control group rather than relying upon
published normative data to interpret test results. In addition, having a control group
would have allowed for the examination of whether or not the observed pattern of
relationships among IL-6, CRP, and cognition would also hold for individuals without
type 2 diabetes. Unfortunately, despite employing a number of methods in an attempt
to recruit controls, only two control participants were tested. Diabetic participants were
recruited via phone calls to individuals listed in the patient database in the diabetes
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clinic. Perhaps obtaining access to a list of patients from a preventative medicine clinic
would yield more fruitful recruiting results for controls.
Another weakness of the study was the small number of men in the sample.
Reportedly, the research recruitment of African American males can be especially
problematic (M. Norman, personal communication, May 25, 2007). Greater wariness
about participating in research among African Americans has been documented in a
study (Corbie-Smith, Thomas, & St. George, 2002) in which results indicated that
distrust of research was significantly higher among males. Suggestions for increasing
research recruitment success in the African American community included engaging in
ongoing community involvement even when research recruitment is not occurring.
In summary, this research advances our understanding of the ways in which type
2 diabetes impairs cognition in older adults, and the potential mechanisms underlying
such cognitive deficits. While most studies examining this topic have focused on older
adult Caucasians, this study was the first specifically aimed at examining cognitive
functioning in older African-Americans with type 2 diabetes. Further, this is the first
study to examine the impact of both chronic hyperglycemia and inflammation on
cognitive functioning in a group of older adults with type 2 diabetes. Results showed
that, on average, cognitive functioning was in the average range in this sample of older
African American adults with type 2 diabetes. A certain proportion of the group,
however, displayed significant cognitive deficits and, as predicted, those deficits were
predominantly in executive functioning rather than in the domain of memory. In future
research it will be important to establish which variables best account for the
predominantly executive cognitive deficits among certain older adults with type 2
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diabetes. Based on the pattern of effects observed in the present study, it appears that
chronic and acute glucose levels would be important predictors, and that using a larger
sample size would allow for the detection of smaller effect sizes on the various
executive functioning measures. This research is important because extensive
evidence indicates that cognitive impairment limits the capacity to self-manage medical
problems and follow medical recommendations in various medical populations. In order
to adhere to a diabetes management plan, a patient must not only remember medical
instructions, but must also have the cognitive capacity necessary to implement them
correctly and consistently (Park & Kidder, 1996). Results of one study suggest that
executive functioning and working memory are critical predictors of medication
adherence. Specifically, a composite of executive function and working memory tasks
was the only significant predictor of medication adherence in a group of 95 elderly
adults when entered into a regression equation with several other predictors, including
age, mental status exam score, a composite memory test score, education, illness
severity, financial well-being, and depression (Insel, Morrow, Brewer, & Figueredo,
2006). Given that a portion of older adults with type 2 diabetes exhibit executive
function deficits, future research should investigate whether the executive deficits
observed in some older adults with type 2 diabetes are also predictive of poor
medication adherence.
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